Table 1.
Clinical characteristics of the Crohn's disease population
| Parameters | n (%) | mean ± SD |
| Disease activity (n = 38) | ||
| In remission | 34 (89.4) | |
| Moderate activity | 4 (10.52) | |
| Severe activity | 0 (0) | |
| Disease Location (n = 35) | ||
| Ileum (L1) | 12 (34.3) | |
| Colon (L2) | 8 (22.9) | |
| Ileocolonic (L3) | 15 (42.9) | |
| Upper digestive tract (L4) | 0 (0) | |
| Phenotype (n = 31) | ||
| Non-stricturing and non-penetrating (B1) | 6 (19.4) | |
| Stricturing (B2) | 9 (29.0) | |
| Penetrating (B3) | 16 (51.6) | |
| Surgery (n = 38) | ||
| None | 18 (47.4) | |
| Small bowel resection | 5 (13.1) | |
| Colonic resection | 3 (7.9) | |
| Other procedures | 12 (31.6) | |
| Medical treatment (n = 38) | ||
| 5-ASA | 25 (65.8) | |
| Immunosuppressants | 28 (73.7) | |
| Corticosteroids | 3 (7.9) | |
| Anti-TNF therapy | 3 (7.9) | |
| Antibiotics | 1 (2.6) | |
| Body composition parameters (n = 34) | ||
| LBM (kg) | 42.01 ± 11.63 | |
| BMC (kg) | 2.39 ± 9.73 | |
| Body fat (kg) | 20.34 ± 0.51 | |
| Body fat (%) | 31.59 ± 10.89 |
LBM: Lean body mass; BMC: Bone mineral content.